Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination

Por St Germain Carly, O'Brien Anna, Dimitroulakos Jim
Publicado em 2010-09-01

Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination

Por St Germain, Carly, O'Brien, Anna, Dimitroulakos, Jim
Publicado em 2010

Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors

Por Zhao, Tong T., Trinh, Diane, Addison, Christina L., Dimitroulakos, Jim
Publicado em 2010

Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells

Por Ma, Laurie, Niknejad, Nima, Gorn-Hondermann, Ivan, Dayekh, Khalil, Dimitroulakos, Jim
Publicado em 2012

Cisplatin Induces Cytotoxicity through the Mitogen-Activated Protein Kinase Pathways and Activating Transcription Factor 3

Por St. Germain, Carly, Niknejad, Nima, Ma, Laurie, Garbuio, Kyla, Hai, Tsonwin, Dimitroulakos, Jim
Publicado em 2010

miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels

Por Honeywell, D. Rice, Cabrita, Miguel A., Zhao, Huijun, Dimitroulakos, Jim, Addison, Christina L.
Publicado em 2013

Microarray and Biochemical Analysis of Lovastatin-Induced Apoptosis of Squamous Cell Carcinomas

Por Dimitroulakos, Jim, Marhin, Wilson H, Tokunaga, Jason, Irish, Jonathan, Gullane, Patrick, Penn, Linda Z, Kamel-Reid, Suzanne
Publicado em 2002

Assessment of Circulating LncRNAs Under Physiologic and Pathologic Conditions in Humans Reveals Potential Limitations as Biomarkers

Por Schlosser, Kenny, Hanson, Jennifer, Villeneuve, Patrick J., Dimitroulakos, Jim, McIntyre, Lauralyn, Pilote, Louise, Stewart, Duncan J.
Publicado no Sci Rep (2016)

The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells

Por Weberpals, Johanne I, O'Brien, Anna M, Niknejad, Nima, Garbuio, Kyla D, Clark-Knowles, Katherine V, Dimitroulakos, Jim
Publicado em 2011

Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells()()

Por Bar, Jair, Hasim, Mohamed S., Baghai, Tabassom, Niknejad, Nima, Perkins, Theodore J., Stewart, David J., Sekhon, Harmanjatinder S., Villeneuve, Patrick J., Dimitroulakos, Jim
Publicado no Neoplasia (2016)

A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies

Por Goss, Glenwood D., Jonker, Derek J., Laurie, Scott A., Weberpals, Johanne I., Oza, Amit M., Spaans, Johanna N., la Porte, Charles, Dimitroulakos, Jim
Publicado no J Transl Med (2016)

Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer

Por Howe, Grant A., Xiao, Bin, Zhao, Huijun, Al-Zahrani, Khalid N., Hasim, Mohamed S., Villeneuve, James, Sekhon, Harmanjatinder S., Goss, Glenwood D., Sabourin, Luc A., Dimitroulakos, Jim, Addison, Christina L.
Publicado no PLoS One (2016)